INSM - Insmed Incorporated
NEXT EARNINGS:
Apr 30, 2026
EPS Est: $-0.97
|
Rev Est: $298.9M
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$214.47
DETAILS
HIGH:
$269.00
LOW:
$166.00
MEDIAN:
$212.00
CONSENSUS:
$214.47
UPSIDE:
35.21%
Market Cap:
33.83B
Volume:
1,693,244
Avg Volume:
3,085,141
52 Week Range:
60.4-212.75
Sector:
Healthcare
Industry:
Biotechnology
Beta:
1.12
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
US
Employees:
1,271
IPO Date:
2000-06-01
EPS (TTM):
-6.41
P/E Ratio:
-29.12
Revenue (TTM):
606.42M
Total Assets:
2.26B
Total Debt:
768.16M
Cash & Equiv:
510.44M
Rev Growth (5Y):
29.8%
EPS Growth (5Y):
N/A
FCF Growth (5Y):
N/A
ROCE:
-63.3%
Debt/Equity:
1.04
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2026-02-19 | $-1.54 | $-1.07 | -43.9% | $263.8M | $231.2M | +14.1% |
| 2025-10-30 | $-1.75 | $-1.33 | -31.6% | $142.3M | $115.4M | +23.3% |
| 2025-08-07 | $-1.70 | $-1.30 | -30.8% | $107.4M | $104.1M | +3.2% |
| 2025-05-08 | $-1.42 | $-1.34 | -6.0% | $92.8M | $91.5M | +1.5% |
| 2025-02-20 | $-1.32 | $-1.17 | -12.8% | $104.4M | $102.1M | +2.3% |
| 2024-10-31 | $-1.27 | $-1.20 | -5.8% | $93.4M | $93.4M | 0.0% |
| 2024-08-08 | $-1.94 | $-1.24 | -56.5% | $90.3M | $88.0M | +2.7% |
| 2024-05-09 | $-1.06 | $-1.24 | +14.5% | $75.5M | $77.8M | -2.9% |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 606.42M | 363.71M | 305.21M | 245.36M | 188.46M | 164.41M | 136.47M | 9.84M | 0 | 0 | 0 | 11.50M |
| Net Income | (1.28B) | (913.77M) | (749.57M) | (481.53M) | (434.65M) | (294.09M) | (254.34M) | (324.28M) | (192.65M) | (176.27M) | (118.18M) | (79.16M) |
| EPS | -6.41 | -5.57 | -5.34 | -3.91 | -3.88 | -3.01 | -3.01 | -4.22 | -2.89 | -2.85 | -2.02 | -1.84 |
| Total Assets | 2.26B | 2.03B | 1.33B | 1.66B | 1.24B | 796.15M | 742.30M | 604.56M | 462.05M | 237.96M | 356.56M | 230.86M |
| Total Debt | 768.16M | 1.31B | 1.20B | 1.18B | 612.27M | 404.84M | 397.04M | 316.56M | 55.57M | 54.79M | 25.14M | 24.86M |
| Cash & Equivalents | 510.44M | 555.03M | 482.37M | 1.07B | 716.78M | 532.76M | 487.43M | 495.07M | 381.17M | 162.59M | 282.88M | 159.23M |
| Operating Cash Flow | (935.01M) | (683.88M) | (536.25M) | (400.44M) | (363.30M) | (219.35M) | (250.65M) | (257.98M) | (159.62M) | (146.71M) | (100.70M) | (64.42M) |
| Free Cash Flow | (967.58M) | (705.80M) | (549.53M) | (410.32M) | (370.59M) | (226.17M) | (292.92M) | (272.79M) | (162.62M) | (150.91M) | (104.15M) | (69.77M) |
| FCF per Share | -4.53 | -4.30 | -3.91 | -3.33 | -3.31 | -2.32 | -3.46 | -3.55 | -2.44 | -2.44 | -1.78 | -1.62 |
| Book Value | 738.98M | 285.38M | (331.92M) | 87.95M | 410.47M | 275.88M | 261.67M | 208.27M | 361.06M | 154.48M | 311.70M | 186.24M |
| Cash & ST Investments | 1.43B | 1.43B | 780.45M | 1.15B | 716.78M | 532.76M | 487.43M | 495.07M | 381.17M | 162.59M | 282.88M | 159.23M |
| ROC Equity | -1.73 | -3.20 | N/A | -5.48 | -1.06 | -1.07 | -0.97 | -1.56 | -0.53 | -1.14 | -0.38 | -0.43 |